SEC Form 4 · accession 0001479791-18-000019
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Oct 31, 2018
Accepted (ET)
Nov 1, 2018 · 1:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| restricted common shares of INVO Bioscience | Oct 31, 2018 | A | 910,878 | $0.39 | A | 26,194,000 | D |
Table II — derivative securities
No Table II lines on this filing.